These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 1843813)

  • 21. Comparative evaluation of adsorption with E. coli on ELISA tests for Lyme borreliosis.
    Fawcett PT; Rose CD; Gibney KM
    J Rheumatol; 1995 Apr; 22(4):684-8. PubMed ID: 7791164
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development and laboratory evaluation of a new recombinant ELISA for the serodiagnosis of Lyme disease.
    Hunfeld KP; Ernst M; Zachary P; Jaulhac B; Sonneborn HH; Brade V
    Wien Klin Wochenschr; 2002 Jul; 114(13-14):580-5. PubMed ID: 12422605
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [False positive serological tests for Borrelia burgdorferi in patients with primary antiphospholipid syndrome].
    Selva O'Callaghan A; Ordi Ros J; Porcel Pérez JM; Tolosa Vilella C; Jordana Comajuncosa R; Juste Sánchez C; Vilardell Tarrés M
    Med Clin (Barc); 1990 Oct; 95(11):411-3. PubMed ID: 2082109
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Persistence of immunoglobulin M or immunoglobulin G antibody responses to Borrelia burgdorferi 10-20 years after active Lyme disease.
    Kalish RA; McHugh G; Granquist J; Shea B; Ruthazer R; Steere AC
    Clin Infect Dis; 2001 Sep; 33(6):780-5. PubMed ID: 11512082
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Borrelia burgdorferi infection in UK horses.
    Carter SD; May C; Barnes A; Bennett D
    Equine Vet J; 1994 May; 26(3):187-90. PubMed ID: 8542836
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnosis of Lyme borreliosis: non-specific serological reactions with Borrelia burgdorferi sonicate antigen caused by IgG2 antibodies.
    Seppälä IJ; Kroneld R; Schauman K; Forsen KO; Lassenius R
    J Med Microbiol; 1994 Apr; 40(4):293-302. PubMed ID: 8151682
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The presence of antibodies to Borrelia burgdorferi associated with immunologic complexes in sera of foresters].
    Sobieszczańska BM; Nózka B; Milczarska J; Dobracka B; Dobracki W
    Med Dosw Mikrobiol; 1998; 50(1-2):97-103. PubMed ID: 9857619
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Interpretation of borreliosis serology. Step-wise diagnosis--introduction to case examples].
    Hassler D; Maiwald M
    Fortschr Med; 1998 Oct; 116(29):20-2, 24. PubMed ID: 9846470
    [No Abstract]   [Full Text] [Related]  

  • 29. Detection of serum antibodies against Borrelia burgdorferi with some commercially available serological tests.
    Melby K; Steinbakk M; Jensenius M; Figenschau KJ
    NIPH Ann; 1990 Dec; 13(2):37-44. PubMed ID: 2093855
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunodiagnosis of Lyme borreliosis.
    Dattwyler RJ; Luft BJ
    Rheum Dis Clin North Am; 1989 Nov; 15(4):727-34. PubMed ID: 2685927
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Western immunoblot and flagellum enzyme-linked immunosorbent assay for serodiagnosis of Lyme borreliosis.
    Karlsson M
    J Clin Microbiol; 1990 Sep; 28(9):2148-50. PubMed ID: 2229399
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term study of Lyme borreliosis in a highly endemic area in Sweden.
    Berglund J; Eitrem R; Norrby SR
    Scand J Infect Dis; 1996; 28(5):473-8. PubMed ID: 8953677
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of Western immunoblotting and the C6 Lyme antibody test for laboratory detection of Lyme disease.
    Mogilyansky E; Loa CC; Adelson ME; Mordechai E; Tilton RC
    Clin Diagn Lab Immunol; 2004 Sep; 11(5):924-9. PubMed ID: 15358654
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Preparations for serodiagnosis of diseases due to causative agents of ixode tick-borne Borreliosis (Lyme disease). Communication 2. Comparative study of recombinant enzyme immunoassay test-systems (rELISA) for serological diagnosis of ixode tick-borne Borreliosis].
    Manzeniuk IN; Vorob'eva MS; Nikitiuk NM; Arumova EA; Anan'eva LP; Baranova SG; Viatkina TG; Masiago AV; Kozarenko AA; Andreĭchuk IuA
    Antibiot Khimioter; 2004; 49(8-9):25-8. PubMed ID: 15727142
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cross-reactivity to Borrelia burgdorferi proteins in serum samples from residents of a tropical country nonendemic for Lyme disease.
    Burkot TR; Schriefer ME; Larsen SA
    J Infect Dis; 1997 Feb; 175(2):466-9. PubMed ID: 9203675
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dominant epitopes of the C6 diagnostic peptide of Borrelia burgdorferi are largely inaccessible to antibody on the parent VlsE molecule.
    Embers ME; Jacobs MB; Johnson BJ; Philipp MT
    Clin Vaccine Immunol; 2007 Aug; 14(8):931-6. PubMed ID: 17567769
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of Western blot and enzyme-linked immunosorbent assay for diagnosis of Lyme borreliosis.
    Karlsson M; Möllegård I; Stiernstedt G; Wretlind B
    Eur J Clin Microbiol Infect Dis; 1989 Oct; 8(10):871-7. PubMed ID: 2512131
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sarcoidosis and ELISA for Borrelia burgdorferi.
    Morris JT; Longfield RN
    South Med J; 1994 Jun; 87(6):590-1. PubMed ID: 8202765
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical and serological features of patients with suspected Lyme borreliosis.
    Santino I; Longobardi V
    Int J Immunopathol Pharmacol; 2011; 24(3):797-801. PubMed ID: 21978712
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The laboratory diagnosis of ocular Lyme borreliosis.
    Mikkilä H; Karma A; Viljanen M; Seppälä I
    Graefes Arch Clin Exp Ophthalmol; 1999 Mar; 237(3):225-30. PubMed ID: 10090586
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.